Kineret (Amgen Inc) en es it fr

Kineret (Amgen Inc) Brand names, Kineret (Amgen Inc) Analogs

Kineret (Amgen Inc) Brand Names Mixture

  • No information avaliable

Kineret (Amgen Inc) Chemical_Formula


Kineret (Amgen Inc) RX_link

Kineret (Amgen Inc) fda sheet

Kineret (Amgen Inc) msds (material safety sheet)

Kineret (Amgen Inc) Synthesis Reference

No information avaliable

Kineret (Amgen Inc) Molecular Weight


Kineret (Amgen Inc) Melting Point

No information avaliable

Kineret (Amgen Inc) H2O Solubility

No information avaliable

Kineret (Amgen Inc) State


Kineret (Amgen Inc) LogP


Kineret (Amgen Inc) Dosage Forms


Kineret (Amgen Inc) Indication

For treatment of adult rheumatoid arthritis

Kineret (Amgen Inc) Pharmacology

Used to treat rheumatoid arthritis, Kineret blocks the biologic activity of IL-1 by competitively inhibiting IL-1 binding to the interleukin-1 type I receptor (IL-1RI), which is expressed in a wide variety of tissues and organs.1 IL-1 production is induced in response to inflammatory stimuli and mediates various physiologic responses including inflammatory and immunological responses. Patients with rheumatoid arthritis have elevated levels of IL-1. The levels of the naturally occurring IL-1Ra in synovium and synovial fluid from rheumatoid arthritis (RA) patients are not sufficient to compete with the elevated amount of locally produced IL-1. Increasing the levels of IL-1Ra by artificial means reduces the negative effects (cartilage degradation, bone resorption) of IL-1.

Kineret (Amgen Inc) Absorption

No information avaliable

Kineret (Amgen Inc) side effects and Toxicity

No information avaliable

Kineret (Amgen Inc) Patient Information


Kineret (Amgen Inc) Organisms Affected

Humans and other mammals